Retatrutide
Price range: $180.00 through $350.00
Retatrutide is a cutting-edge tri-agonist peptide that is transforming the field of metabolic research. Designed to simultaneously activate the GLP-1, GIP, and GCGR (glucagon) receptors, this multifunctional peptide offers a more comprehensive and synergistic approach to modulating appetite, enhancing insulin function, and accelerating fat metabolism.
| Weight | 0.011 lbs |
|---|---|
| Dimensions | 1.25 × 0.75 × 0.75 in |
| Dose | 10mg, 12mg, 20mg, 30mg |
Retatrutide
An investigational triple receptor agonist (GLP-1, GIP, glucagon). Developed for advanced metabolic and weight management research. Currently under clinical evaluation.
Retatrutide
An investigational triple receptor agonist (GLP-1, GIP, glucagon). Developed for advanced metabolic and weight management research. Currently under clinical evaluation.
Retatrutide Smart Pen
An advanced smart injection pen for accurate retatrutide administration. Designed for controlled and user-friendly subcutaneous delivery. Currently studied for metabolic health and weight management applications.
Retatrutide Smart Pen
An advanced smart injection pen for accurate retatrutide administration. Designed for controlled and user-friendly subcutaneous delivery. Currently studied for metabolic health and weight management applications.
RETATRUTIDE
A clinical trial drug targeting GLP-1, GIP, and glucagon receptors, under investigation for weight loss and metabolic health.
RETATRUTIDE
An investigational medication exploring its potential in weight management and metabolic health by activating three key receptors.
RETATRUTIDE
A triple receptor agonist being studied for its effects on metabolism and obesity, currently in clinical trials.
RETATRUTIDE
A promising drug targeting GLP-1, GIP, and glucagon receptors to support weight loss and metabolic improvements, still under clinical research.
